The historical performance of IDEXX Laboratories over the past 20 years, with an average annual return of 11.64%, indicates a strong and consistent growth trajectory. This performance, significantly above the market average, suggests a positive outlook for the company's stock in the short term, especially considering its substantial market capitalization of $44.59 billion. The information highlights the company's ability to generate value for its investors over a long period, which could attract more interest in the stock.